Figure 1:Axial CT
Abdominal imaging
Case TypeClinical Cases
Authors
Haesung Lee DO1, Amit Hudgi3, Supanee Rassameehiran MD2, Jayanth Keshavamurthy MD1
Sridhar Subbaramiah MD2
54 years, female
[1] Nishino M1, Hayakawa K, Nakamura Y, Morimoto T, Mukaihara S. (2003) Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy. AJR Am J Roentgenol 2003 Jan;180(1):129-34. (PMID: 12490491)
[2] Vaishali Patel, MBBS, MD and Arun J. Sanyal, MBBS, MD (2013) Drug-Induced Steatohepatitis. Clin Liver Dis 17(4): 533–vii. (PMID: 24099016)
[3] Okka W. Hamer, Diego A. Aguirre, Giovanna Casola, Joel E. Lavine, Matthias Woenckhaus, Claude B. Sirlin (2006) Fatty Liver: Imaging Patterns and Pitfalls. RadioGraphics Vol. 26, No. 6
[4] Malcolm M. Wells,Zhe Lin, Bryan Addeman ,Charles A. McKenzie , Amol Mujoomdar, Melanie Beaton, and Jeffery Bird (2016) Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. Cannadian Journal of Gastroenterology and Hepatology Article ID 4930987
[5] Scott B. Reeder and Claude Sirlin (2011) Quantification of Liver Fat with Magnetic Resonance Imaging. Magnetic Resonance Imaging Clinics of North America Volume 18, Issue 3,Pages 337-357 (PMID: 21094444)
URL: | https://eurorad.org/case/15976 |
DOI: | 10.1594/EURORAD/CASE.15976 |
ISSN: | 1563-4086 |
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.